Quinquenel A, Lepretre S, Dilhuydy MS, Bussot L, et al. Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS). Ann Hematol 2025 Jul 30. doi: 10.1007/s00277-025-06498.
PMID: 40736551